iSpecimen Inc. Segment Reporting Other Item Amount
iSpecimen Inc. (ISPC) reported Segment Reporting Other Item Amount of $837.24 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Segment Reporting
us-gaap:SegmentReportingOtherItemAmount · last filed 2026-08-14
- iSpecimen Inc. segment reporting other item amount for the quarter ending 2026-06-30 was $423.38K, a 153.39% increase year-over-year.
- iSpecimen Inc. segment reporting other item amount for the quarter ending 2026-03-31 was $413.86K, a 44.36% decline year-over-year.
- iSpecimen Inc. segment reporting other item amount for the quarter ending 2025-12-31 was $3.20M, a 59.51% increase year-over-year.
- iSpecimen Inc. segment reporting other item amount for the quarter ending 2025-09-30 was $799.72K, a 32.29% increase year-over-year.
- iSpecimen Inc. segment reporting other item amount for fiscal 2025 was $4.91M, a 12.30% decline from fiscal 2024.
- iSpecimen Inc. segment reporting other item amount for fiscal 2024 was $5.60M, a 4.46% decline from fiscal 2023.
- iSpecimen Inc. segment reporting other item amount for fiscal 2023 was $5.86M.
| Period end | Segment Reporting Other Item Amount 3 month | Segment Reporting Other Item Amount 6 month | Segment Reporting Other Item Amount 9 month | Segment Reporting Other Item Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | $423.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $837.24K 10-Q · filed 2026-08-14 | $4.03M derived: sum of 3 quarters · filed 2026-08-14 | $4.83M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $413.86K 10-Q · filed 2026-05-18 | $3.61M derived: sum of 2 quarters · filed 2026-05-18 | $4.41M derived: sum of 3 quarters · filed 2026-05-18 | $4.58M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $3.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $4.00M derived: sum of 2 quarters · filed 2026-04-01 | $4.16M derived: sum of 3 quarters · filed 2026-08-14 | $4.91M 10-K · filed 2026-04-01 |
| 2025-09-30 | $799.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | $966.81K derived: sum of 2 quarters · filed 2026-08-14 | $1.71M 10-Q · filed 2025-11-17 | $3.71M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $167.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $910.96K 10-Q · filed 2026-08-14 | $2.91M derived: sum of 3 quarters · filed 2026-08-14 | $3.52M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $743.87K 10-Q · filed 2026-05-18 | $2.75M derived: sum of 2 quarters · filed 2026-05-18 | $3.35M derived: sum of 3 quarters · filed 2026-05-18 | $4.32M derived: sum of 4 quarters · filed 2026-05-18 |
| 2024-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $2.61M derived: sum of 2 quarters · filed 2026-04-01 | $3.58M derived: sum of 3 quarters · filed 2026-04-01 | $5.60M 10-K · filed 2026-04-01 |
| 2024-09-30 | $604.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-17 | $1.58M derived: sum of 2 quarters · filed 2025-11-17 | $3.59M 10-Q · filed 2025-11-17 | |
| 2024-06-30 | $971.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $2.99M 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | $2.02M 10-Q · filed 2025-05-19 | |||
| 2023-12-31 | $5.86M 10-K · filed 2025-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |